news Axiall sells two PVC operations
US chemicals group Axiall Corporation has announced the sale of two rigid PVC businesses, the Solucor PVC compound additives operation and the window and door profiles unit of its Royal Building Products division. The company has sold
certain assets of the Solucor additives operation, including its manufacturing facility at Bradford, Ontario, Canada, to Galata Chemicals. The Bradford facility manufactures mostly process aids and impact modifiers for rigid PVC applications and employs around 60 people. The deal completed in February. The window and door
profiles business of Royal is to
Celanese puts more focus on PA
Celanese has announced plans to grow its Engi- neered Materials portfolio with the addition of polyamide 6 and 66 products produced using proprietary technologies including melt impregna- tion and blends. The company is under-
stood to be sourcing base polymer for the new grades externally. In a statement, it said some of the new grades will be available immediately while some will not be introduced until the third quarter of this year. ❙
www.celanese.com
10
tives activities. Commenting specifically on the window and door profile disposal, he said the move leaves Royal Building Products active in the siding, trim moulding, and fittings markets, where EBITDA margins are stronger. Galata Chemicals said the
Axiall is to focus its PVC activities on cholorvinyls and derivatives
be sold to private equity firm OpenGate Capital in a deal expected to close at the end of this month. It includes the Axiall PVC compounding facility at Concord in Ontario. Axiall Corporation - which is currently fending off an
unsolicited take-over bid by US-based Westlake Chemical Corporation - described both of the businesses as non-core. Axiall President and CEO Tim Mann said the disposals will allow it to better focus on its core chlorovinyls and deriva-
Solucor business was a strong and complementary addition to its product portfolio. “The purchase of Solucor is another key step in Galata’s growth strategy as we continue to pursue additional strategic acquisitions,” said Vishal Goenka, Director of Galata Chemical parent company Artek Surfin Chemicals. ❙
www.axiall.com ❙
www.galatachemicals.com
LehVoss says China production expansion is ‘on schedule’
Germany-headquartered Lehmann&Voss&Co, which makes the Luvocom range of high-performance compounds and Luvosint additives, has announced that its planned expansion of sales and production in China is on schedule. A new manufacturing
operation has now started in Kunshan, approximately 60 km west of Shanghai, the company said. Lehvoss New Material (Kunshan) covers 2,500 m² and features extrusion plant, a laboratory, a development department, application technology and offices. Production will focus on the Luvocom and Luvosint ranges.
COMPOUNDING WORLD | March 2016 Alongside the manufactur-
ing investment, the company said that its sales subsidiary, Lehvoss (Shanghai) Chemical Trading, which was originally
founded in January 2014, is now located in larger premises in the Changning area of the Shanghai. ❙
www.lehvoss.de
New Lehmann & Voss operation in China will produce Luvocom compounds
www.compoundingworld.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104
